Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01243892 · ClinicalTrials.gov registry record
A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device
A clinical trial, sponsored by Genentech.
- Terminated
- Registry status
- 18
- Enrollment target
NCT01243892: Clinical Trial study, sponsored by Genentech.
NCT01243892 is a clinical trial that was terminated before completion, run by Genentech. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01243892 was terminated before completion, sponsored by Genentech.
- TERMINATED
- Registry status
- 18 participants
- Enrollment target
Study Summary
This is a Phase IV, open label, case-controlled, observational study to evaluate the age-adjusted cumulative height velocity in pre-pubertal isolated growth hormone deficient (IGHD) and idiopathic short stature (ISS) participants receiving daily doses of somatropin (recombinant human growth hormone \[rhGH\]; Nutropin) using NuSpin device compared to historical controls from the national cooperative growth study (NCGS).
Primary Outcome
The annualized height velocity (cm per year \[cm/yr\]) over 2 years was calculated as: \[(height in cm at t24 minus (-) height in cm at t0) divided by (date at t24 - date at t0)\] multiplied by 365.25, where, t0 is the baseline measurement visit and t24 is the 2-year measurement visit.
Interventions
- DRUG Somatropin
- DEVICE NuSpin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2010-11 |
| Est. Completion | 2011-08 |
Why NCT01243892 stopped before completion
NCT01243892 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Somatropin is the first listed.
NCT01243892 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01243892 about?
NCT01243892 is a clinical study titled "A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device". This is a Phase IV, open label, case-controlled, observational study to evaluate the age-adjusted cumulative height velocity in pre-pubertal isolated growth hormone deficient (IGHD) and idiopathic short stature (ISS) participants receiving daily doses of somatropin (recombinant human growth hormone ...
What is the current status of trial NCT01243892?
This trial is currently terminated. The enrollment target is 18 participants. The study started on 2010-11. Estimated completion is 2011-08.
What interventions are being tested in trial NCT01243892?
The interventions under investigation include: Somatropin (DRUG), NuSpin (DEVICE).
Who is sponsoring clinical trial NCT01243892?
This trial is sponsored by Genentech, which has 332 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia